Results 11 to 20 of about 1,047 (134)

Identifying Tumefactive Demyelination on Synthetic MRI Myelin Maps [PDF]

Case Reports in Radiology
Tumefactive demyelinating lesions and brain neoplasms often present as a diagnostic challenge due to overlapping radiographic features among conventional imaging modalities ultimately resulting in uncertainty if a biopsy is warranted to establish a ...
Brandon Simons, Rebecca Li, Tushar Chandra, Laura Hayes   +3 more
doaj   +3 more sources

Tumefactive Demyelinating Lesion Induced by Infliximab in a Patient With Rheumatoid Arthritis: A Case Report [PDF]

Clinical Case Reports
Tumor Necrosis Factor‐alpha (TNF‐α) inhibitors have been successfully used to treat rheumatoid arthritis (RA), psoriatic and ankylosing arthritis, and inflammatory bowel disease.
Shahla Mohammed Saeed Rasul, Zana Abdulrahman Mohammed, Aran Asaad Adiban, Yahya Jawad Kadhm   +3 more
doaj   +3 more sources

Tumefactive demyelinating lesions: a case report and literature review [PDF]

BMC Neurology
Tumefactive multiple sclerosis (TMS) is a rare and diagnostically challenging variant of demyelinating disease that frequently mimics neoplastic, infectious, or vascular brain lesions.
Raneem Jaki, Zyad Al-Frejat, Ziad Bitar
doaj   +2 more sources

Case report: A novel case of COVID-19 triggered tumefactive demyelinating lesions in one multiple sclerosis patient [PDF]

Frontiers in Neuroscience, 2023
The epidemic of COVID-19 is mainly manifested by respiratory symptoms caused by SARS-CoV-2 infection. Recently, reports of central nervous system diseases caused or aggravated by SARS-CoV-2 infection are also increasing. Thus, the COVID-19 pandemic poses
Jinghan Hu, Leiyun Huang, Zengyun Qiu, Yongzhen Liu, Kaiming Shen, Bin Tang, Jing Qian, Jing Qian   +7 more
doaj   +2 more sources

Tumefactive demyelinating lesions: a retrospective cohort study in Thailand [PDF]

Scientific Reports
Tumefactive demyelinating lesions (TDL), characterized by large (≥ 2 cm) demyelinating lesions mimicking tumors, are a rare manifestation of the central nervous system inflammatory demyelinating diseases (CNS-IDD).
Tatchaporn Ongphichetmetha, Saharat Aungsumart, Sasitorn Siritho, Metha Apiwattanakul, Jantima Tanboon, Natthapon Rattanathamsakul, Naraporn Prayoonwiwat, Jiraporn Jitprapaikulsan   +7 more
doaj   +2 more sources

Subgroup analysis of tumefactive demyelinating lesions: clinical, imaging features and outcomes [PDF]

BMJ Neurology Open
Background Tumefactive demyelinating lesions (TDLs) are rare, large demyelinating lesions of the central nervous system that can mimic brain tumours in radiological appearance. They have been observed across multiple demyelinating diseases.
Zheng Liu, Dawei Li, Yuqi Tang, Zhandong Qiu, Yingyue Ding, Huiqing Dong   +5 more
doaj   +2 more sources

Tumefactive demyelinating lesions: A Clinicopathological correlative study

Indian Journal of Pathology and Microbiology, 2012
Tumefactive demyelinating (TDL) lesions are focal zones of demyelination in the central nervous system and they often mimic the neuroimaging features of an intraxial neoplasm.
R Neelima, K Krishnakumar, M D Nair, C Kesavadas, Divyata Rajendra Hingwala, V V Radhakrishnan, Sruthi S Nair   +6 more
doaj   +3 more sources

Non‐Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature

Annals of the Child Neurology Society
Introduction Tumefactive demyelinating lesions (TDLs) are large lesions (> 2 cm) seen in demyelinating syndromes such as multiple sclerosis, myelin oligodendrocyte glycoprotein antibody‐associated disorder, and neuromyelitis optica spectrum disorder ...
Elizabeth C. Ballinger, Hannah F. Todd, Jonathan M. Yarimi, Timothy E. Lotze, Nikita M. Shukla, Kristen S. Fisher, Alexander J. Sandweiss   +6 more
doaj   +2 more sources

Tumefactive Demyelinating Lesion Mimicking Low-Grade Astrocytoma with a T2/FLAIR Mismatch Sign: A Case Report and Review of the Literature [PDF]

Diagnostics
Background and Clinical Significance: Tumefactive demyelinating lesions (TDLs) are large demyelinating lesions that mimic intracranial tumors, posing a diagnostic challenge in both clinical presentation and conventional imaging.
Maria Karhu, Roberts Tumeļkāns, Dace Dzirkale, Kaspars Auslands, Can Özütemiz, Alīna Flintere Flinte, Arturs Balodis   +6 more
doaj   +2 more sources

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers [PDF]

Frontiers in Immunology
ObjectiveWe present a case of multiple tumefactive demyelinating lesions (TDLs) emerging 24 months after the second cycle of alemtuzumab treatment.MethodsA woman with relapsing-remitting multiple sclerosis (MS) discontinued fingolimod treatment due to ...
Neus Rabaneda-Lombarte, Aina Teniente-Serra, Aina Teniente-Serra, Anna Massuet-Vilamajó, Cristina Ramo-Tello, Silvia Presas-Rodríguez   +5 more
doaj   +2 more sources